EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Development and validation of a dementia risk prediction model for low- and middle-income countries: the 10/66 study

Eduwin Pakpahan, Zhongyang Guan, Mario Siervo, Graciela Muniz-Terrera, Devi Mohan, Daisy Acosta, Ana Luisa Sosa, Isaac Acosta, Juan J Llibre-Rodriguez, Jorge J Llibre-Guerra, Martin Prince, Alice Worrall, Aliya Naheed, Ashleigh S Vella, Jiyang Jiang, Darren M Lipnicki, Perminder S Sachdev, Louise Robinson, Matthew Prina, Blossom C M Stephan

American Journal of Epidemiology · 2026-11-04 · 195 (11) · 2710-2718

DOI: 10.1093/aje/kwag116 ↗
AbstractBibliografische Angaben

Abstract

Abstract Most people with dementia live in low- and middle-income countries (LMICs), underscoring the need for LMIC-specific identification of high-risk individuals. This study aimed to develop and validate a simple dementia risk prediction model for these settings. Data from 7 10/66 Study sites were analyzed. Over 100 candidate predictors were screened based on existing models and the 2024 Lancet Commission, including LMIC-specific variables (eg, food insecurity and household assets). Predictors were selected using LASSO and modelled with the Fine–Gray method to generate a risk score. Predictive accuracy was pooled via meta-analysis. Eleven thousand one hundred forty-three participants were included, among whom 1069 (9.6%) developed dementia during follow-up. A 5-factor risk score comprising age, social engagement, physical activity, hypertension, and difficulty in handling money was developed. The pooled c-statistic was 0.75 (95% CI, 0.72-0.78), with good calibration across sites. Decision curve analysis showed a modest net benefit, with variation across countries. It is possible to predict incident dementia with reasonable accuracy using a simple model across different LMICs. Our findings support the use of context-specific risk assessment tools to identify individuals at elevated dementia risk in LMIC settings, which may inform resource allocation for dementia care services and public health planning.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →